Navigation Links
Cotara in Medical News

Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009

... At the same time, we advanced our bavituximab and cotara clinical trials in FY 2009 while keeping R&D c...ology platform." Mr. King continued, "Our cotara clinical program continues to advance with patient...icine 2009 Annual Meeting, further confirming that cotara specifically localizes to brain tumors at high con...

Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program

...Phase I and Phase II Clinical Trials Have Received cotara to Date, with a Good Safety Profile and Longer-Ter...patient enrollment in the final cohort of a second cotara GBM trial, a dose confirmation and dosimetry study... than 65 patients with recurrent GBM have received cotara in the current and previous clinical studies. Loc...

Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials

...fficacy trial. In patients treated in the studies, cotara appears to be safe and well tolerated, with no dos..."We are encouraged by early results from these two cotara clinical studies and look forward to presenting da...s in this trial receive an initial imaging dose of cotara before receiving the therapeutic dose. The study's...

Peregrine Pharmaceuticals Initiates Patient Enrollment In New Cotara(R) Brain Cancer Trial

...dly form of brain cancer. In pilot studies cotara has shown encouraging results, demonstrating a 58%...ma trials would provide a foundation for advancing cotara into Phase III trials. "Cotara has demonst...ry and dosing data being collected in ongoing U.S. cotara trials, will help us determine the optimal design ...
Cotara in Medical Technology

Data To Be Presented at ASCO Supports Potential of Peregrine's Cotara(R) for the Treatment of Brain Cancer

...s with minimal radiation exposure to other organs. cotara is a targeted monoclonal antibody linked to a radi...a multiforme (GBM), a deadly form of brain cancer. cotara specifically targets cells at the center of brain ...study, confirming other clinical data showing that cotara appears to have a good safety profile. The...

Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India

...aging signs of anti-tumor activity seen in earlier cotara brain cancer studies," said Steven W. King, presid...ective is to confirm the maximum tolerated dose of cotara in these GBM patients. Secondary objectives includ...ts in the trial are receiving a single infusion of cotara by convection-enhanced delivery (CED), an NIH-deve...
Cotara in Biological Technology

Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine

...se, and it can produce large quantities of labeled drug product rapidly, reliably and cost-effectively. We have been using the new process to produce cotara for our ongoing brain cancer trials and can report that it works as well in clinical practice as it does in the lab. We believe it is significant tha...

Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrine's Cotara(R) for the Treatment of Brain Cancer

... with minimal radiation exposure to other organs. cotara is a targeted monoclonal antibody linked to a radi...rst two cohorts of the study, the concentration of cotara in brain tumors was on average more than 300-fold ...al time of six months for recurrent GBM patients. cotara is currently being tested in this Phase I dose res...

Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009

...rior bavituximab cancer study and from our ongoing cotara study in glioblastoma (GBM) patients at the presti...(R) Brain Cancer Program: Peregrine advanced the cotara brain cancer program during the quarter. -- Presented data from the cotara dosing and dosimetry study at the ASCO 2008 Annual...

Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008

...tudy in HCV patients co-infected with HIV, and two cotara studies for the treatment of glioblastoma multifor...we strengthened the foundation for progress in the cotara clinical program by initiating additional sites in two ongoing trials of cotara in patients with GBM. Data was presented at the 20...

Peregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breast Cancer Study

... in brain tumors, leaving healthy tissue in the body largely unaffected. The release also reported that all of the GBM patients treated to date in the cotara Phase II safety and efficacy trial have survived past the expected median survival time for relapsed GBM patients, an early but encouraging result. Th...

Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008

... distinguished brain cancer center and experienced cotara clinical study site -- the Barrow Neurological Ins...tiative to raise awareness for the bavituximab and cotara programs in the scientific and medical communities...ek of an abstract discussing patient data from the cotara dosimetry trial for presentation at the 2008 ASCO ...

Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008

...nd demonstrated encouraging signs of anti-viral activity. Cotara(R) Brain Cancer Clinical Program To help accelerate the ongoing Phase II trial of cotara in patients with glioblastoma multiforme, one of the most deadly forms of brain cancer, Peregrine recently added two new sites to the study, for a tot...
Other Tags
(Date:4/17/2014)... Hospital Pediatrician-in-Chief Jon McCullers, MD, was recently invited ... of Nature Reviews Microbiology , one of ... a world-renowned infectious disease specialist, and chair of ... Tennessee Health Science Center, analyzed the epidemiology and ... 1968 pandemics, as well as more recent 2009 ...
(Date:4/17/2014)... cause of neuronal death in Parkinson,s disease is still ... be mistaken for foreign invaders and killed by the ... diseases like type I diabetes, celiac disease, and multiple ... April 16, 2014, in Nature Communications . , ... Parkinson,s disease; but if true, it could lead to ...
(Date:4/17/2014)... An international team led by researchers at UC Davis ... plays a key role in cell division, also boosts ... the first time the complex has been shown to ... B1/Cdk1 an excellent target to control cellular energy production, ... was published online today in the journal Developmental ...
(Date:4/17/2014)... 2014 Meaningful long-term survival is possible for ... abdomen when treated with cytoreductive surgery with Hyperthermic ... analysis by physicians at Wake Forest Baptist Medical ... reported, single-center experience with cytoreductive surgery and HIPEC, ... analysis of 20 years, worth of patient data ...
(Date:4/17/2014)... adrenaline after they suffer a cardiac arrest outside of ... long-term, according to new research conducted at St. Michael,s ... a cardiac arrest get adrenaline, which has been the ... Dr. Steve Lin, an emergency physician and trauma team ... treatment, long-term survival rates of patients who suffer a ...
Breaking Medicine News(10 mins):Health News:Is Parkinson's an autoimmune disease? 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:20 years of data shows treatment technique improvement for advanced abdominal cancer 2Health News:Adrenaline does little to increase patient's survival after cardiac arrest 2
(Date:4/17/2014)... The White House honored Clemson professor Rajendra Singh ... efforts to promote and expand solar deployment in ... the D. Houser Banks Professor of Electrical and ... Silicon Nanoelectronics, is considered a local hero leading ... and economic opportunity in solar power and driving ...
(Date:4/17/2014)... serious conditions such as heart disease, epilepsy and pain, ... Unfortunately, there is still much scientists do not know ... unexpected insight into the structure of sodium channels and, ... which are responsible for ,fine-tuning, the activity of the ... edition of the Journal of Biological Chemistry . ...
(Date:4/17/2014)... the University of Texas Medical Branch at Galveston ... treated with radiation for cervical cancer should begin ... , The UTMB researchers, finding a high incidence ... treated with radiation, offer new recommendations that the ... screening about eight years after their initial cervical ...
Breaking Biology News(10 mins):White House honors Clemson professor as 'Champion of Change' for solar deployment 2Structure of sodium channels different than previously believed 2Radiation therapy for cervical cancer increases risk for colorectal cancer 2
Other Contents